Amplifier Therapeutics, a Cambrian Bio PipeCo, is focused on the development of AMP-activated protein kinase (AMPK) activator compounds to treat diseases associated with aging including metabolic conditions, cardiovascular diseases, kidney diseases, and cancer.
As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.
Company Details
- Employees
- 2
- Industry
- Biotechnology
- Website
- https://www.amplifier-tx.com
Amplifier Therapeutics Questions
Amplifier Therapeutics's website is https://www.amplifier-tx.com
Amplifier Therapeutics's LinkedIn profile is https://www.linkedin.com/company/amplifier-therapeutics
Amplifier Therapeutics has
2 employees.
View email and phone details for 2
employees at Amplifier Therapeutics.
Amplifier Therapeutics's industry is
Biotechnology
Amplifier Therapeutics's top competitors are
Tornado Therapeutics,
Upstream Bio,
Viking Therapeutics, Inc.,
Chroma Medicine,
Remedium Bio,
Terns Pharmaceuticals,
Delix Therapeutics,
Cambrian Bio,
Sparrow Pharmaceuticals, Inc.,
Avilar Therapeutics.
Amplifier Therapeutics's categories are Biotechnology
